Toll-like Receptor 4-mediated Apoptotic Cell Death in Primary Isolated Human Cervical Cancers |
Won, Jinyoung
(Department of Rehabilitation Science, Graduate School of Inje University)
Hong, Yunkyung (u-Healthcare & Anti-aging Research Center (u-HARC), Inje University) Park, Sookyoung (u-Healthcare & Anti-aging Research Center (u-HARC), Inje University) Kim, Joo-Heon (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Hong, Yonggeun (Department of Rehabilitation Science, Graduate School of Inje University) |
1 | Kawai, T. and Akira, S. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13, 460-469. DOI |
2 | Kiraz, Y., Adan, A., Kartal Yandim, M. and Baran, Y. 2016. Major apoptotic mechanisms and genes involved in apoptosis. Tumour. Biol. 37, 8471-8486. DOI |
3 | Liu, Y., Hu, X., Han, C., Wang, L., Zhang, X., He, X. and Lu, X. 2015. Targeting tumor suppressor genes for cancer therapy. Bioessays 37, 1277-1286. DOI |
4 | Maxwell, S. A. and Davis, G. E. 2000. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc. Natl. Acad. Sci. USA. 97, 13009-13014. DOI |
5 | Minig, L., Padilla-Iserte, P. and Zorrero, C. 2016. The relevance of gynecologic oncologists to provide high-quality of care to women with gynecologic cancer. Front. Oncol. 5, 308. |
6 | Mitchell, J. A., Shynlova, O., Langille, B. L. and Lye, S. J. 2004. Mechanical stretch and progesterone differentially regulate activator protein-1 transcription factors in primary rat myometrial smooth muscle cells. Am. J. Physiol. Endocrinol. Metab. 287, 439-445. DOI |
7 | Palmberg, L. and Thyberg, J. 1986. Uterine smooth muscle cells in primary culture. Alterations in fine structure, cytoskeletal organization and growth characteristics. Cell Tissue Res. 246, 253-262. DOI |
8 | Piccinini, A. M. and Midwood, K. S. 2010. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, pii: 672395. |
9 | Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A. and D'Orazi, G. 2016. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging 8, 603-619. DOI |
10 | Janeway, C. A. Jr. and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216. DOI |
11 | Suh, D. H., Kim, M., Kim, H. J., Lee, K. H. and Kim, J. W. 2016. Major clinical research advances in gynecologic cancer in 2015. J. Gynecol. Oncol. 27, e53. DOI |
12 | Radogna, F., Dicato, M. and Diederich, M. 2015. Cancertype-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target. Biochem. Pharmacol. 94, 1-11. DOI |
13 | Scott, S. H. and Bahnson, B. J. 2011. Senescence marker protein 30: functional and structural insights to its unknown physiological function. Biomol. Concepts 2, 469-480. |
14 | Smits, E. L., Ponsaerts, P., Berneman, Z. N. and Van, Tendeloo, V. F. 2008. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist 13, 859-875. DOI |
15 | Soussi, T. 2007. p53 alterations in human cancer: more questions than answers. Oncogene 26, 2145-2156. DOI |
16 | Sporn, M. B. and Roberts, A. B. 1985. Autocrine growth factors and cancer. Nature 313, 745-747. DOI |
17 | Tan, R. S., Ho, B., Leung, B. P. and Ding, J. L. 2014. TLR cross-talk confers specificity to innate immunity. Int. Rev. Immunol. 33, 443-453. DOI |
18 | Tyson, J. J. and Novak, B. 2014. Control of cell growth, division and death: information processing in living cells. Interface Focus 4, 20130070. DOI |
19 | Wang, Y., Weng, Y., Shi, Y., Xia, X., Wang, S. and Duan, H. 2014. Expression and functional analysis of Toll-like receptor 4 in human cervical carcinoma. J. Membr. Biol. 247, 591-599. DOI |
20 | Preedy, V. R. and Watson, R. R. 2010. Handbook of Disease Burdens and Quality of Life Measures, pp. 803-823, Springer, NY, USA. |
21 | Witsch, E., Sela, M. and Yarden, Y. 2010. Roles for growth factors in cancer progression. Physiology (Bethesda) 25, 85-101. |
22 | Fulda, S. 2013. Regulation of cell death in cancer-possible implications for immunotherapy. Front. Oncol. 3, 29. |
23 | Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. 2002. The Cell Cycle and Programmed Cell Death. Mol. Biol. Cell. pp. 983-1026, 4th ed., Garland Science, NY, USA. |
24 | Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J. and Strasser, A. 2018. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell. Death. Differ. 25, 104-113. DOI |
25 | Yin, J. G., Liu, X. Y., Wang, B., Wang, D. Y., Wei, M., Fang, H. and Xiang, M. 2016. Gene expression profiling analysis of ovarian cancer. Oncol. Lett. 12, 405-412. DOI |
26 | Zhang, Y., Luo, F., Li, A., Qian, J., Yao, Z., Feng, X. and Chu, Y. 2014. Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice. Clin. Immunol. 154, 26-36. DOI |
27 | Biewenga, P., Buist, M. R., Moerland, P. D., Ver Loren van Themaat, E., van Kampen, A. H., ten Kate, F. J. and Baas, F. 2008. Gene expression in early stage cervical cancer. Gynecol. Oncol. 108, 520-526. DOI |
28 | Chhabra, S. and Kutchi, I. 2013. Fertility preservation in gynecologic cancers. Clin. Med. Insights Reprod. Health 7, 49-59. |
29 | Fleck, J. L., Pavel, A. B. and Cassandras, C. G. 2016. Integrating mutation and gene expression cross-sectional data to infer cancer progression. BMC. Syst. Biol. 10, 12. DOI |
30 | Fukata, M., Chen, A., Klepper, A., Krishnareddy, S., Vamadevan, A. S., Thomas, L. S., Xu, R., Inoue, H., Arditi, M., Dannenberg, A. J. and Abreu, M. T. 2006. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131, 862-877. DOI |
31 | Goustin, A. S., Leof, E. B., Shipley, G. D. and Moses, H. L. 1986. Growth factors and cancer. Cancer Res. 46, 1015-1029. |
32 | He, W., Liu, Q., Wang, L., Chen, W., Li, N. and Cao, X. 2007. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol. Immunol. 44, 2850-2859. DOI |
33 | Hanahan, D. and Weinberg, R. A. 2011. Hallmarks of cancer: the next generation. Cell 144, 646-674. DOI |
34 | Hong, Y., Won, J., Lee, Y., Lee, S., Park, K., Chang, K. T. and Hong, Y. 2014. Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. J. Pineal. Res. 56, 264-274. DOI |
35 | Iribarren, K., Bloy, N., Buque, A., Cremer, I., Eggermont, A., Fridman, W. H., Fucikova, J., Galon, J., Spísek, R., Zitvogel, L., Kroemer, G. and Galluzzi, L. 2015. Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology 5, e1088631. |
36 | Iguchi, Y. Ito, Y. M., Kataoka, F., Nomura, H., Tanaka, H., Chiyoda, T., Hashimoto, S., Nishimura, S., Takano, M., Yamagami, W., Susumu, N., Aoki, D. and Tsuda, H. 2014. Simultaneous analysis of the gene expression profiles of cancer and stromal cells in endometrial cancer. Genes Chromosomes Cancer 53, 725-737. DOI |